SEARCH

SEARCH BY CITATION

References

  • 1
    Lindberg RA, Quinn AM & Hunter T (1992) Dual-specificity protein kinases: will any hydroxyl do? Trends Biochem Sci 17, 114119.
  • 2
    Schaeffer HJ & Weber MJ (1999) Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol 19, 24352444.
  • 3
    Dhanasekaran N & Premkumar Reddy E (1998) Signaling by dual specificity kinases. Oncogene 17, 14471455.
  • 4
    Ben-David Y, Letwin K, Tannock L, Bernstein A & Pawson T (1991) A mammalian protein kinase with potential for serine/threonine and tyrosine phosphorylation is related to cell cycle regulators. EMBO J 10, 317325.
  • 5
    Kentrup H, Becker W, Heukelbach J, Wilmes A, Schürmann A, Huppertz C, Kainulainen H & Joost HG (1996) Dyrk, a dual specificity protein kinase with unique structural features whose activity is dependent on tyrosine residues between subdomains VII and VIII. J Biol Chem 271, 34883495.
  • 6
    Howell BW, Afar DE, Lew J, Douville EM, Icely PL, Gray DA & Bell JC (1991) STY, a tyrosine-phosphorylating enzyme with sequence homology to serine/threonine kinases. Mol Cell Biol 11, 568572.
  • 7
    Nolen B, Taylor S & Ghosh G (2004) Regulation of protein kinases; controlling activity through activation segment conformation. Mol Cell 15, 661675.
  • 8
    Saul VV, de la Vega L, Milanovic M, Krüger M, Braun T, Fritz-Wolf K, Becker K & Schmitz ML (2013) HIPK2 kinase activity depends on cis-autophosphorylation of its activation loop. J Mol Cell Biol 5, 2738.
  • 9
    Becker W & Sippl W (2010) Activation, regulation, and inhibition of DYRK1A. FEBS J 278, 246256.
  • 10
    Fu Z, Schroeder MJ, Shabanowitz J, Kaldis P, Togawa K, Rustgi AK, Hunt DF & Sturgill TW (2005) Activation of a nuclear Cdc2-related kinase within a mitogen-activated protein kinase-like TDY motif by autophosphorylation and cyclin-dependent protein kinase-activating kinase. Mol Cell Biol 25, 60476064.
  • 11
    Siepi F, Gatti V, Camerini S, Crescenzi M & Soddu S (2013) HIPK2 catalytic activity and subcellular localization are regulated by activation-loop Y354 autophosphorylation. Biochim Biophys Acta 1833, 14431453.
  • 12
    Lee K, Du C, Horn M & Rabinow L (1996) Activity and autophosphorylation of LAMMER protein kinases. J Biol Chem 271, 2729927303.
  • 13
    Lochhead PA, Sibbet G, Morrice N & Cleghon V (2005) Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs. Cell 121, 925936.
  • 14
    Lochhead PA, Kinstrie R, Sibbet G, Rawjee T, Morrice N & Cleghon V (2006) A chaperone-dependent GSK3beta transitional intermediate mediates activation-loop autophosphorylation. Mol Cell 24, 627633.
  • 15
    Lochhead PA (2009) Protein kinase activation loop autophosphorylation in cis: overcoming a Catch-22 situation. Sci Signal 2, pe4.
  • 16
    Becker W & Sippl W (2011) Activation, regulation, and inhibition of DYRK1A. FEBS J 278, 246256.
  • 17
    Adayev T, Chen-Hwang M-C, Murakami N, Lee E, Bolton DC & Hwang Y-W (2007) Dual-specificity tyrosine phosphorylation-regulated kinase 1A does not require tyrosine phosphorylation for activity in vitro. Biochemistry 46, 76147624.
  • 18
    Kinstrie R, Luebbering N, Miranda-Saavedra D, Sibbet G, Han J, Lochhead PA & Cleghon V (2010) Characterization of a domain that transiently converts class 2 DYRKs into intramolecular tyrosine kinases. Sci Signal 3, ra16.
  • 19
    Han J, Miranda-Saavedra D, Luebbering N, Singh A, Sibbet G, Ferguson MAJ & Cleghon V (2012) Deep evolutionary conservation of an intramolecular protein kinase activation mechanism. PLoS One 7, e29702.
  • 20
    Tejedor FJ & Hämmerle B (2011) MNB/DYRK1A as a multiple regulator of neuronal development. FEBS J 278, 223235.
  • 21
    Park J, Song W-J & Chung KC (2009) Function and regulation of Dyrk1A: towards understanding Down syndrome. Cell Mol Life Sci 66, 32353240.
  • 22
    Göckler N, Jofre G, Papadopoulos C, Soppa U, Tejedor FJ & Becker W (2009) Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation. FEBS J 276, 63246337.
  • 23
    Rush J, Moritz A, Lee KA, Guo A, Goss VL, Spek EJ, Zhang H, Zha X-M, Polakiewicz RD & Comb MJ (2005) Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat Biotechnol 23, 94101.
  • 24
    Mott BT, Tanega C, Shen M, Maloney DJ, Shinn P, Leister W, Marugan JJ, Inglese J, Austin CP, Misteli T et al. (2009) Evaluation of substituted 6-arylquinazolin-4-amines as potent and selective inhibitors of cdc2-like kinases (Clk). Bioorg Med Chem Lett 19, 67006705.
  • 25
    Ogawa Y, Nonaka Y, Goto T, Ohnishi E, Hiramatsu T, Kii I, Yoshida M, Ikura T, Onogi H, Shibuya H et al. (2010) Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A. Nat Commun 1, 86. doi:10.1038/ncomms1090.
  • 26
    Fedorov O, Huber K, Eisenreich A, Filippakopoulos P, King O, Bullock AN, Szklarczyk D, Jensen LJ, Fabbro D, Trappe J et al. (2011) Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing. Chem Biol 18, 6776.
  • 27
    Pagano MA, Bain J, Kazimierczuk Z, Sarno S, Ruzzene M, Di Maira G, Elliott M, Orzeszko A, Cozza G, Meggio F et al. (2008) The selectivity of inhibitors of protein kinase CK2: an update. Biochem J 415, 353365.
  • 28
    Sarno S, Reddy H, Meggio F, Ruzzene M, Davies SP, Donella-Deana A, Shugar D & Pinna LA (2001) Selectivity of 4,5,6,7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 (‘casein kinase-2’). FEBS Lett 496, 4448.
  • 29
    Eswaran J & Knapp S (2010) Insights into protein kinase regulation and inhibition by large scale structural comparison. Biochim Biophys Acta 1804, 429432.
  • 30
    De Graaf K, Czajkowska H, Rottmann S, Packman LC, Lilischkis R, Lüscher B & Becker W (2006) The protein kinase DYRK1A phosphorylates the splicing factor SF3b1/SAP155 at Thr434, a novel in vivo phosphorylation site. BMC Biochem 7, 7.
  • 31
    Himpel S, Panzer P, Eirmbter K, Czajkowska H, Sayed M, Packman LC, Blundell T, Kentrup H, Grötzinger J, Joost HG et al. (2001) Identification of the autophosphorylation sites and characterization of their effects in the protein kinase DYRK1A. Biochem J 359, 497505.
  • 32
    Saul VV, de la Vega L, Milanovic M, Krüger M, Braun T, Fritz-Wolf K, Becker K & Schmitz ML (2012) HIPK2 kinase activity depends on cis-autophosphorylation of its activation loop. J Mol Cell Biol 5, 2738.
  • 33
    Soundararajan M, Roos AK, Savitsky P, Filippakopoulos P, Kettenbach AN, Olsen JV, Gerber SA, Eswaran J, Knapp S & Elkins JM (2013) Structures of Down syndrome kinases, DYRKs, reveal mechanisms of kinase activation and substrate recognition. Structure 21, 986996.
  • 34
    Kassis S, Melhuish T, Annan RS, Chen SL, Lee JC, Livi GP & Creasy CL (2000) Saccharomyces cerevisiae Yak1p protein kinase autophosphorylates on tyrosine residues and phosphorylates myelin basic protein on a C-terminal serine residue. Biochem J 348, 263272.
  • 35
    Papadopoulos C, Arato K, Lilienthal E, Zerweck J, Schutkowski M, Chatain N, Müller-Newen G, Becker W & de la Luna S (2011) Splice variants of the dual specificity tyrosine phosphorylation-regulated kinase 4 (DYRK4) differ in their subcellular localization and catalytic activity. J Biol Chem 286, 54945505.
  • 36
    Lee K, Deng X & Friedman E (2000) Mirk protein kinase is a mitogen-activated protein kinase substrate that mediates survival of colon cancer cells. Cancer Res 60, 36313637.
  • 37
    Lochhead PA, Sibbet G, Kinstrie R, Cleghon T, Rylatt M, Morrison DK & Cleghon V (2003) dDYRK2: a novel dual-specificity tyrosine-phosphorylation-regulated kinase in Drosophila. Biochem J 374, 381391.
  • 38
    Kida E, Walus M, Jarząbek K, Palminiello S, Albertini G, Rabe A, Hwang YW & Golabek AA (2011) Form of dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 1A nonphosphorylated at tyrosine 145 and 147 is enriched in the nuclei of astroglial cells, adult hippocampal progenitors, and some cholinergic axon terminals. Neuroscience 195, 112127.
  • 39
    Wiechmann S, Czajkowska H, de Graaf K, Grötzinger J, Joost H-G & Becker W (2003) Unusual function of the activation loop in the protein kinase DYRK1A. Biochem Biophys Res Commun 302, 403408.
  • 40
    Dajani R, Fraser E, Roe SM, Young N, Good V, Dale TC & Pearl LH (2001) Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell 105, 721732.
  • 41
    Dajani R, Fraser E, Roe SM, Yeo M, Good VM, Thompson V, Dale TC & Pearl LH (2003) Structural basis for recruitment of glycogen synthase kinase 3beta to the axin-APC scaffold complex. EMBO J 22, 494501.
  • 42
    Bax B, Carter PS, Lewis C, Guy AR, Bridges A, Tanner R, Pettman G, Mannix C, Culbert AA, Brown MJ et al. (2001) The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation. Structure 9, 11431152.
  • 43
    Ter Haar E, Coll JT, Austen DA, Hsiao HM, Swenson L & Jain J (2001) Structure of GSK3beta reveals a primed phosphorylation mechanism. Nat Struct Biol 8, 593596.
  • 44
    Kannan N & Neuwald AF (2004) Evolutionary constraints associated with functional specificity of the CMGC protein kinases MAPK, CDK, GSK, SRPK, DYRK, and CK2alpha. Protein Sci 13, 20592077.
  • 45
    Boyer SH, Ugarkar BG, Solbach J, Kopcho J, Matelich MC, Ollis K, Gomez-Galeno JE, Mendonca R, Tsuchiya M, Nagahisa A et al. (2005) Adenosine kinase inhibitors. 5. Synthesis, enzyme inhibition, and analgesic activity of diaryl-erythro-furanosyltubercidin analogues. J Med Chem 48, 64306441.
  • 46
    Becker W, Weber Y, Wetzel K, Eirmbter K, Tejedor FJ & Joost HG (1998) Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases. J Biol Chem 273, 2589325902.
  • 47
    Savaldi-Goldstein S, Sessa G & Fluhr R (2000) The ethylene-inducible PK12 kinase mediates the phosphorylation of SR splicing factors. Plant J 21, 9196.
  • 48
    Menegay HJ, Myers MP, Moeslein FM & Landreth GE (2000) Biochemical characterization and localization of the dual specificity kinase CLK1. J Cell Sci 113, 32413253.
  • 49
    Tzarum N, Diskin R, Engelberg D & Livnah O (2011) Active mutants of the TCR-mediated p38α alternative activation site show changes in the phosphorylation lip and DEF site formation. J Mol Biol 405, 11541169.
  • 50
    Nitta RT, Chu AH & Wong AJ (2008) Constitutive activity of JNK2 alpha2 is dependent on a unique mechanism of MAPK activation. J Biol Chem 283, 3493534945.